BioMarin Pharma (BMRN) Misses Q1 EPS by 14c
Tweet
Share
E-mail
Get Alerts BMRN Hot Sheet
Price: $66.70 -1.45%
Financial Fact:
NET INCOME (LOSS): -42.8M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
NET INCOME (LOSS): -42.8M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
BioMarin Pharma (NASDAQ: BMRN) reported Q1 EPS of ($0.32), $0.14 worse than the analyst estimate of ($0.18). Revenue for the quarter came in at $400 million versus the consensus estimate of $389.69 million.
- 2019 Full-Year Financial Guidance unchanged
For earnings history and earnings-related data on BioMarin Pharma (BMRN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $59 at H.C. Wainwright
- Bill.com (BILL) Tops Q4 EPS by 14c, Beats on Revenue; Offers FY27 Guidance
- Deere & Co. (DE) Tops Q3 EPS by 41c, raises guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
